Docetaxel

DOCETAXEL 20MG 1MD Vial

DOCETAXEL 160MG 16MD Vial

DOCETAXEL 20MG 1MD Vial

About: Docetaxel (Taxotere)

Docetaxel is approved in treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate cancer.

Docetaxel is also being investigated to treat small cell lung, ovarian, bladder, and pancreatic cancers, soft tissue sarcoma and melanoma. Docetaxel is given through a vein (intravenously, IV).

There is no pill form of docetaxel.

Docetaxel belongs to a class of chemotherapy drugs called plant alkaloids. Plant alkaloids are made from plants. The plant alkaloids are cell-cycle specific meaning they attack the cells during various phases of division.

Docetaxel may also be used for purposes not listed above.

INDICATIONS

Breast Cancer

TAXOTERE is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy.

TAXOTERE in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.

Non-Small Cell Lung Cancer

TAXOTERE as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. TAXOTERE in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer who have not previously received chemotherapy for this condition.

Prostate Cancer

TAXOTERE in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer.

Gastric Adenocarcinoma

TAXOTERE in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for advanced disease.

Head and Neck Cancer

TAXOTERE in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

COMMONLY PURCHASED TOGETHER

Cisplatin
Cyclophosphamide
Doxorubicin
Fluorouracil
Ondansetron
Prednisone
Palonosetron

REQUEST MORE INFO

Delivering the medication

YOU NEED

WHEN YOU NEED IT

even during periods of

shortages in the market.